GNCAUnknown

GENOCEA BIOSCIENCES, INC. Insider Trading Activity

Every SEC Form 4 insider transaction reported for GENOCEA BIOSCIENCES, INC. (GNCA), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are GNCA insiders buying or selling?

GENOCEA BIOSCIENCES, INC. insiders reported 37 open-market buys ($241.9M) and 28 sells ($6.8M) across 65 Form 4 filings — a net buying position of $235.1M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jun 3, 2022)

Total Form 4 filings
65
SEC EDGAR
Insider filers
22
Insider buys (37)
$241.9M
Insider sells (28)
$6.8M

Insider sentiment

Net buying

Net insider flow of $235.1M in net buying.

Recent GNCA insider transactions

DateInsiderRoleTypeSharesPriceValue
Jun 3, 2022Diantha DuvallCHIEF FINANCIAL OFFICERSale1.4K$0.06$81.3
Jun 3, 2022Jessica Baker FlechtnerChief Scientific OfficerSale1.6K$0.06$94.68
Jun 3, 2022William D ClarkPresident and CEOSale4.0K$0.06$241.38
Jun 2, 2022Jacquelyn L SumerCHIEF LEGAL & COMPLIANCE OFFSale2.5K$0.06$150.25
Jun 2, 2022William D ClarkPresident and CEOSale117.2K$0.06$7.2K
Jun 1, 2022George SiberDirectorSale20.4K$0.07$1.3K
May 26, 2022Paul Edward Walker10% OwnerSale10.4M$0.07$750.7K
May 26, 2022Peter W. Sonsini10% OwnerSale10.4M$0.07$750.7K
May 26, 2022Scott D Sandell10% OwnerSale10.4M$0.07$750.7K
May 26, 2022New Enterprise Associates 16, L.P.10% OwnerSale10.4M$0.07$750.7K
May 26, 2022Mohamad Makhzoumi10% OwnerSale10.4M$0.07$750.7K
May 26, 2022Anthony A. Florence Jr.10% OwnerSale10.4M$0.07$750.7K
May 26, 2022Carmen Chang10% OwnerSale10.4M$0.07$750.7K
May 26, 2022Ali BehbahaniDirector, 10% OwnerSale10.4M$0.07$750.7K
May 26, 2022Forest Baskett10% OwnerSale10.4M$0.07$750.7K
May 26, 2022Raymond D Stapleton JRCHIEF TECHNOLOGY OFFICERSale2.5K$0.09$222.5
May 26, 2022Jessica Baker FlechtnerChief Scientific OfficerSale16.5K$0.09$1.5K
May 26, 2022Diantha DuvallCHIEF FINANCIAL OFFICERSale24.4K$0.08$1.9K
Apr 5, 2022Jessica Baker FlechtnerChief Scientific OfficerSale1.2K$1.25$1.5K
Apr 5, 2022Diantha DuvallCHIEF FINANCIAL OFFICERSale963$1.25$1.2K
Apr 5, 2022Thomas Andrew DavisCHIEF MEDICAL OFFICERSale1.1K$1.25$1.4K
Apr 5, 2022William D ClarkPresident and CEOSale3.9K$1.25$4.9K
Apr 5, 2022Girish N AakaluCHIEF BUSINESS OFFICERSale963$1.25$1.2K
Mar 17, 2022Jessica Baker FlechtnerChief Scientific OfficerSale3.3K$1.10$3.7K
Mar 17, 2022Diantha DuvallCHIEF FINANCIAL OFFICERSale2.9K$1.10$3.2K

Showing the 25 most recent of 65 Form 4 filings for GENOCEA BIOSCIENCES, INC..

Most active GNCA insiders

  • William D Clark5 filings
  • Ali Behbahani4 filings
  • Anthony A. Florence Jr.4 filings
  • Carmen Chang4 filings
  • Diantha Duvall4 filings

Ask anything about GNCA insider activity

Use Trabud's AI agent to query GENOCEA BIOSCIENCES, INC.'s Form 4 history in plain English — "Show me GNCA CEO purchases this year" or compare it against any other ticker.

Open the AI agent

GNCA insider trading FAQ

Are GENOCEA BIOSCIENCES, INC. insiders buying or selling?

Across 65 SEC Form 4 filings, GENOCEA BIOSCIENCES, INC. (GNCA) insiders reported 37 open-market purchases totaling $241.9M and 28 sales totaling $6.8M. That is a net buying position of $235.1M.

How many insiders trade GNCA stock?

22 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for GENOCEA BIOSCIENCES, INC.. The most recent filing was accepted on Jun 3, 2022.

Where does Trabud get GNCA insider trading data?

All GNCA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content